The depletion of HAUSP in breast cancer cells or the use of P5091, a HAUSP inhibitor, resulted in a dramatic increase in LSD1 ubiquitination, a decrease in LSD1 protein levels, and an increase in the methylation of H3K4me2 and H3K9me2. This evidence concerns the gene KDM1A and breast cancer.